CNY 12.01
(1.09%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 174.26 Thousand | 40.37 Million | -22.79 Million | 66.78 Million | 94.77 Million | 94.37 Million |
Net Income | -52.45 Million | 60.48 Million | 81 Million | 100.8 Million | 107.53 Million | 100.52 Million |
Depreciation & Amortization | 14.72 Million | 10.28 Million | 7.24 Million | 8.12 Million | 7.26 Million | 6.86 Million |
Deferred income taxes | -18.06 Million | -15.54 Million | -1.8 Million | -1.15 Million | -1.9 Million | -1.84 Million |
Stock-based compensation | 1.02 Million | 1.76 Million | - | - | - | - |
Change in working capital | -124.24 Million | -96.94 Million | -136.29 Million | -45.07 Million | -26.93 Million | -20.78 Million |
Other non-cash items | 14.55 Million | 66.54 Million | 25.25 Million | 2.94 Million | 6.9 Million | 7.76 Million |
Investing Cash Flow | 115.72 Million | -254.47 Million | 302.37 Million | -205.39 Million | -365.86 Million | -3.99 Million |
Investments in PPE | -96.49 Million | -40.71 Million | -16.36 Million | -12.77 Million | -4.34 Million | -5.47 Million |
Acquisitions | 177.73 Thousand | 21 Thousand | 5000.00 | 13.01 Million | 4.46 Million | 5.75 Million |
Investment purchases | -599.33 Million | -2.01 Billion | -1.47 Billion | -1.45 Billion | -752 Million | -2 Million |
Sales/Maturities of investments | 811.38 Million | 1.8 Billion | 1.79 Billion | 1.26 Billion | 390.36 Million | 3.19 Million |
Other Investing Activities | 212.22 Million | 0.83 | 0.74 | -12.77 Million | -4.34 Million | -5.47 Million |
Financing Cash Flow | -48.69 Million | 435.35 Million | -102.82 Million | 17.34 Million | 479.54 Million | - |
Debt repayment | -9.74 Million | -451.71 Million | -60 Million | -60 Million | - | - |
Dividends payments | -44.4 Million | -24.99 Million | -40 Million | -40 Million | - | - |
Common Stock Repurchased | - | -451.9 Million | - | - | - | - |
Common Stock Issuance | - | 184.24 Thousand | - | - | - | - |
Other Financing Activities | -3.04 Million | 1.36 Billion | -368.13 Thousand | 120.03 Million | 479.54 Million | - |
Accounts receivables | -47.91 Million | -155.81 Million | -63.65 Million | -46.93 Million | -77.24 Million | -57.31 Million |
Accounts payables | -58.25 Million | 74.41 Million | -70.82 Million | 3 Million | 52.21 Million | 38.37 Million |
Inventory | - | -28.41 Million | -683.64 Thousand | - | - | - |
Other working capital | 1.58 Million | 12.86 Million | -1.12 Million | -1.15 Million | -1.9 Million | - |
Cash at beginning of period | 785.29 Million | 564.04 Million | 387.28 Million | 508.56 Million | 300.11 Million | 209.73 Million |
Cash at end of period | 852.49 Million | 785.29 Million | 564.04 Million | 387.28 Million | 508.56 Million | 300.11 Million |
Capital Expenditure | -96.49 Million | -40.71 Million | -16.36 Million | -12.77 Million | -4.34 Million | -5.47 Million |
Effect of forex changes on cash | - | -0.09 | - | - | - | - |
Net cash flow / Change in cash | 67.2 Million | 221.24 Million | 176.75 Million | -121.27 Million | 208.44 Million | 90.37 Million |
Free Cash Flow | -96.32 Million | -346.2 Thousand | -39.15 Million | 54.01 Million | 90.42 Million | 88.89 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | -12.63 Million | -100.27 Million | -62.41 Million | -52.45 Million | -8.49 Million |
Depreciation & Amortization | - | 4.41 Million | 4.41 Million | 14.72 Million | 14.72 Million | -6.59 Million |
Deferred income taxes | - | - | - | - | -18.06 Million | -11.71 Million |
Stock-based compensation | - | -694.06 Thousand | - | 1.02 Million | 1.02 Million | -16.62 Million |
Change in working capital | - | -28.88 Million | - | -46.33 Million | -124.24 Million | 34.93 Million |
Other non-cash items | - | 7.95 Million | 82.35 Million | 143.58 Million | 14.55 Million | 20.02 Million |
Investing Cash Flow | -44.46 Million | -43.62 Million | -10.99 Million | 11.49 Million | 115.72 Million | -25.29 Million |
Investments in PPE | - | -86.09 Thousand | -1.71 Million | -6.19 Million | -96.49 Million | 5.13 Million |
Acquisitions | - | 111.64 Thousand | - | - | 177.73 Thousand | 177 Thousand |
Investment purchases | -201.4 Million | -56.85 Million | -14.74 Million | -10.58 Million | -599.33 Million | -128.65 Million |
Sales/Maturities of investments | 156.92 Million | 13.19 Million | 5.47 Million | 28.27 Million | 811.38 Million | 98.05 Million |
Other Investing Activities | 22.4 Thousand | -43.14 Million | -9.27 Million | 17.69 Million | 212.22 Million | 1.27 |
Financing Cash Flow | -3.64 Million | -406.38 Thousand | -425.93 Thousand | 123.83 Thousand | -48.69 Million | -52.21 Million |
Debt repayment | - | - | - | - | -9.74 Million | - |
Dividends payments | -47.00 | - | -5778.96 | -355.56 | -44.4 Million | -44.21 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.64 Million | 420.15 Thousand | -420.15 Thousand | 123.48 Thousand | -3.04 Million | -8 Million |
Accounts receivables | - | -24.16 Million | - | -47.91 Million | -47.91 Million | 38.87 Million |
Accounts payables | - | - | - | - | -58.25 Million | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | -4.72 Million | - | 1.58 Million | 1.58 Million | -3.94 Million |
Cash at beginning of period | 770.01 Million | 827.22 Million | 852.49 Million | 791.32 Million | 785.29 Million | 860.75 Million |
Cash at end of period | 726.54 Million | 773.79 Million | 823.14 Million | 852.49 Million | 852.49 Million | 791.32 Million |
Capital Expenditure | - | -86.09 Thousand | -1.71 Million | -6.19 Million | -96.49 Million | 5.13 Million |
Effect of forex changes on cash | - | - | - | - | - | -3.45 Million |
Net cash flow / Change in cash | -43.47 Million | -53.42 Million | -29.34 Million | 61.17 Million | 67.2 Million | -69.43 Million |
Free Cash Flow | - | -9.18 Million | -19.64 Million | 43.35 Million | -96.32 Million | 16.66 Million |
002702
600888
603001
6055
52D0
OMINFRAL